LY 315902Alternative Names: LY315902
Latest Information Update: 07 Feb 2014
At a glance
- Originator Eli Lilly
- Class Antihyperglycaemics; Peptides
- Mechanism of Action Glucagon-like peptide 1 stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetes mellitus